Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-496

Overview: Adolescents who use cannabis—especially at a younger age or higher frequency—face substantially elevated risks of mood and psychiatric disorders. Listen in to hear practical, evidence-based strategies for screening teens for substance use, counseling patients and families, and recognizing the significant risks associated with adolescent cannabis use.

Episode resource links:

• Young-Wolff KC, Cortez CA, Alexeeff SE, et al. Adolescent Cannabis Use and Risk of Psychotic, Bipolar, Depressive, and Anxiety Disorders. JAMA Health Forum. 2026;7(2):e256839. doi:10.1001/jamahealthforum.2025.6839
• American Academy of Pediatrics - Substance Use and Prevention

Guest: Jillian Joseph, MPAS, PA-C Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-495

Overview: Statin prescription labels and case reports list a variety of potential treatment-related adverse effects that often raise concerns about their safety. In this episode, we review the evidence for such effects from a recently published study of statin therapy, giving you confidence to counsel worried patients.

Episode resource links:

• Explain the concerns over potential negative effects from statin use
• Outline the latest research demonstrating statin safety

Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/quick-take-1-cyclospora

Overview: Cyclospora infections in the US are running far ahead of a typical season, with thousands of suspected and confirmed cases across dozens of states as of mid-July 2026, and the source of the surge still under active investigation. In this Quick Take, we break down what primary care clinicians need to know right now: what this parasite is and how people get exposed, why the current outbreak dwarfs a usual season and why pinning down the source is so difficult, the clinical picture that should put cyclosporiasis on your differential, the testing pitfall that leads to missed diagnoses, and practical guidance for counseling patients on treatment, prevention, and what to expect as the investigation continues to unfold.

Learning Objectives:

1. Describe the biology and transmission of Cyclospora cayetanensis, and why 2026 is far from a typical cyclosporiasis season.
2. Identify the clinical features and exposure history that should raise suspicion for cyclosporiasis, and recognize the testing pitfall that causes routine stool panels to miss it.
3. Counsel patients on treatment, the prolonged course that often outlasts the parasite, prevention, and when to return for care.